ScholarLens Back to search
2011•Journal of Baotou Medical CollegeRequires access

Clinical Research on Batroxobin in Treatment of Patients with Acute Cerebral Infarction

Yinghui Wang

Open publisher page 0 citations

Abstract

Objective: To investigate the clinical effects of batroxobin on the treatment of patients with acute cerebral infarction(ACI).Methods: One hundred and fifty two cases with ACI were collected,and were randomly divided into batroxobin treatment group and control group.The level of plasma fibrinogen and neurological deficit score were determined in all patients before and after the treatment.Results: The level of plasma fibrinogen and neurological deficit score in patients were significantly decreased after treatment with batroxobin.Conclusion: Early use of batroxobin can significantly improve the clinical symptoms of patients with ACI in 6-72 hours from the onset of disease.

About this research paper

What this paper is about

Objective: To investigate the clinical effects of batroxobin on the treatment of patients with acute cerebral infarction(ACI).Methods: One hundred and fifty two cases with ACI were collected,and were randomly divided into batroxobin treatment group and control group.The level of plasma fibrinogen and neurological deficit score were determined in all patients before and after the treatment.Results: The level of plasma fibrinogen and neurological deficit score in patients were significantly decreased after treatment with batroxobin.Conclusion: Early use of batroxobin can significantly improve the clinical symptoms of patients with ACI in 6-72 hours from the onset of disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the clinical effects of batroxobin on the treatment of patients with acute cerebral infarction(ACI).Methods: One hundred and fifty two cases with ACI were collected,and were randomly divided into batroxobin treatment group and control group.The level of plasma fibrinogen and neurological deficit score were determined in all patients before and after the treatment.Results: The level of plasma fibrinogen and neurological deficit score in patients were significantly decreased after treatment with batroxobin.Conclusion: Early use of batroxobin can significantly improve the clinical symptoms of patients with ACI in 6-72 hours from the onset of disease.

Key concepts: Batroxobin, Medicine, Fibrinogen, Cerebral infarction, Neurological deficit, Internal medicine, Disease, Surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Research on Batroxobin in Treatment of Patients with Acute Cerebral Infarction — Research Paper | ScholarLens